These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 29570618)

  • 1. Lysophosphatidic Acid Signaling in Obesity and Insulin Resistance.
    D'Souza K; Paramel GV; Kienesberger PC
    Nutrients; 2018 Mar; 10(4):. PubMed ID: 29570618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis.
    Yang F; Chen GX
    World J Gastroenterol; 2018 Sep; 24(36):4132-4151. PubMed ID: 30271079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking gp130 signaling suppresses autotaxin expression in adipocytes and improves insulin sensitivity in diet-induced obesity.
    Sun S; Wang R; Song J; Guan M; Li N; Zhang X; Zhao Z; Zhang J
    J Lipid Res; 2017 Nov; 58(11):2102-2113. PubMed ID: 28874440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autotaxin-LPA signaling contributes to obesity-induced insulin resistance in muscle and impairs mitochondrial metabolism.
    D'Souza K; Nzirorera C; Cowie AM; Varghese GP; Trivedi P; Eichmann TO; Biswas D; Touaibia M; Morris AJ; Aidinis V; Kane DA; Pulinilkunnil T; Kienesberger PC
    J Lipid Res; 2018 Oct; 59(10):1805-1817. PubMed ID: 30072447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis.
    Rancoule C; Dusaulcy R; Tréguer K; Grès S; Attané C; Saulnier-Blache JS
    Biochimie; 2014 Jan; 96():140-3. PubMed ID: 23639740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidic Acid Inhibits Insulin Signaling in Primary Rat Hepatocytes via the LPA3 Receptor Subtype and is Increased in Obesity.
    Fayyaz S; Japtok L; Schumacher F; Wigger D; Schulz TJ; Haubold K; Gulbins E; Völler H; Kleuser B
    Cell Physiol Biochem; 2017; 43(2):445-456. PubMed ID: 28922661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.
    Tabuchi S
    Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the autotaxin - Lysophosphatidic acid receptor axis in cardiovascular diseases.
    Zhao Y; Hasse S; Zhao C; Bourgoin SG
    Biochem Pharmacol; 2019 Jun; 164():74-81. PubMed ID: 30928673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autotaxin and LPA receptor signaling in cancer.
    Houben AJ; Moolenaar WH
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):557-65. PubMed ID: 22002750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autotaxin-LPA-LPP3 Axis in Energy Metabolism and Metabolic Disease.
    Jose A; Kienesberger PC
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis.
    Orosa B; García S; Conde C
    Eur J Pharmacol; 2015 Oct; 765():228-33. PubMed ID: 26297977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological roles of lysophosphatidic acid signaling through its production by autotaxin.
    Okudaira S; Yukiura H; Aoki J
    Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autotaxin⁻Lysophosphatidic Acid Signaling in Alzheimer's Disease.
    Ramesh S; Govindarajulu M; Suppiramaniam V; Moore T; Dhanasekaran M
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autotaxin Is Regulated by Glucose and Insulin in Adipocytes.
    D'Souza K; Kane DA; Touaibia M; Kershaw EE; Pulinilkunnil T; Kienesberger PC
    Endocrinology; 2017 Apr; 158(4):791-803. PubMed ID: 28324037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autotaxin/Lysophosphatidic Acid Axis: From Bone Biology to Bone Disorders.
    Alioli C; Demesmay L; Peyruchaud O; Machuca-Gayet I
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.
    Tigyi GJ; Yue J; Norman DD; Szabo E; Balogh A; Balazs L; Zhao G; Lee SC
    Adv Biol Regul; 2019 Jan; 71():183-193. PubMed ID: 30243984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic rhinosinusitis with nasal polyps and without nasal polyps is associated with increased expression of lysophosphatidic acid-related molecules.
    Park SJ; Jun YJ; Lee KJ; Hwang SM; Kim TH; Lee SH; Lee SH
    Am J Rhinol Allergy; 2014; 28(3):199-207. PubMed ID: 24980231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Secretion and role of autotaxin and lysophosphatidic acid in adipose tissue].
    Saulnier-Blache JS
    J Soc Biol; 2006; 200(1):77-81. PubMed ID: 17144165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the autotaxin/LPA axis in cancer development and metastasis.
    Leblanc R; Peyruchaud O
    Exp Cell Res; 2015 May; 333(2):183-189. PubMed ID: 25460336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer.
    Meng G; Tang X; Yang Z; Zhao Y; Curtis JM; McMullen TPW; Brindley DN
    FASEB J; 2019 Feb; 33(2):1899-1910. PubMed ID: 30192654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.